Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 4,789-4,800 of 6,115
Drug study icon
CompletedEUCTR 2013-003038-34

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of SM-13496 for the Treatment of Bipolar I Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Lithuania
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.
Countries
Lithuania, Slovakia
Sponsor
Sumitomo Dainippon Pharma Co., Ltd.
Condition
Bipolarity, Depression
Drug study icon
TerminatedEUCTR 2015-000465-31

Cannabidiol in Bipolar Depression – CannaBiD-Study: An 8-week randomized, double-blind, placebo-controlled clinical trial of Cannabidiol as add-on therapy in bipolar depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Germany
Sponsor
Charité - Universitätsmedizin Berlin
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2007-004513-33

Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Bipolarity, Depression
Biological study icon
CompletedEUCTR 2016-004023-24

Effect of erythropoietin (EPO) on cognitive function and frontal lobe activity in patients with Bipolarity and unipolar depression in remission (PRETEC-EPO)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionBiological
Countries
Denmark
Sponsor
Copenhagen Affective Disorder research Center (CADIC), Psychiatric Centre Copenhagen, Rigshospitalet
Condition
Bipolarity, Depression
Drug study icon
TerminatedEUCTR 2006-005506-32

Pain, anxiety and depression in neuropathic and non-neuropathic pain: Effect of monoamine modulation.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDrug
Countries
Denmark
Sponsor
Danish Pain Research Center
Condition
Anxiety, Depression
Drug study icon
CompletedEUCTR 2007-004009-93

Prevalence of depression,anxiety and impulse control disorder (ICD) in patients with Parkinson's disease and effectiveness of escitalopram

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDrug
Countries
Italy
Sponsor
LUNDBECK ITALIA
Condition
Anxiety, Depression
Drug study icon
CompletedEUCTR 2015-002116-32

The effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep disturbances in patients after acute myocardial syndrome

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDrug
Countries
Denmark
Sponsor
Køge Hospital
Condition
Anxiety, Depression
Drug study icon
Recruitment unclearEUCTR 2021-004790-31

A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Bipolar Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Poland
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Poland, Spain
Sponsor
Janssen-Cilag International NV
Condition
Bipolarity, Depression
Other study type icon
Not recruitingISRCTN99961401

Building resilience and resources to reduce depression and anxiety in young people from urban neighbourhoods in Latin America

This observational study is following people with Adolescents with symptoms of depression and anxiety or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Argentina
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionOther
Countries
Argentina, Colombia, Peru
Sponsor
Queen Mary University of London
Condition
Anxiety, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.